<DOC>
	<DOCNO>NCT02188901</DOCNO>
	<brief_summary>B-mode ultrasonography ( B-US ) , standard method surveillance hepatocellular carcinoma ( HCC ) , fair sensitivity 63 % detect early stage HCC . Sonazoid , contrast agent ultrasonography , report superior sensitivity detect focal liver lesion since ability Kupffer phase image well vascular phase imaging . So aim compare detection rate early stage HCC false referral rate HCC B-mode US Sonazoid-enhanced ultrasonography ( S-US ) within prospective data group . Our hypothesis S-US superior detection rate early stage HCC ( 5 % ) B-mode US ( 3 % ) .</brief_summary>
	<brief_title>Contrast ( Sonazoid ) -Enhanced US Screening Tool Hepatocellular Carcinoma Cirrhosis : An Exploratory Cross-sectional Study</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Patient 20 year old old , 2 . Patient high risk HCC suppose take ultrasonography , 3 . Patient suspicious HCC previous examination patient undergoes first surveillance , 4 . Patient liver cirrhosis proven one follow methodsliver biopsy ( METAVIR score 4 ) , identification esophageal gastric varix endoscopically radiologically , surface nodularity ultrasonography , CT MRI , platelet count less 100,000/mm3 , serum albumin less 3.5 g/dl , prothrombin time high 1.3 INR , 5 . Patient without contraindication sonazoid , 6 . Patient willing sign inform consent 1 . Patient pregnancy breast feeding , 2 . Patient allergy egg , 3 . Patient lefttoright shunt , respiratory insufficiency , severe pulmonary hypertension , 4 . Patient history HCC , 5 . Patient history malignancy HCC</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>HCC</keyword>
	<keyword>Sonazoid</keyword>
	<keyword>Ultrasonography</keyword>
	<keyword>Screening</keyword>
</DOC>